Your search returned the following 11 documents:

11. Efficacy of antiretroviral therapy switch in HIV-infected patients: A 10-year analysis of the EuResist cohort
    Mark Oette, Eugen Schulter, Michal Rosen-Zvi, Yardena Peres, Maurizio Zazzi, Anders Sonnerborg, Daniel Struck, Andre Altmann, and Rolf Kaiser
    Intervirology 55 (2): 160-166, 2012
    
10. History-alignment models for bias-aware prediction of virological response to HIV combination therapy
    Jasmina Bogojeska, Daniel Stöckel, Maurizio Zazzi, Rolf Kaiser, Francesca Incardona, Michal Rosen-Zvi, and Thomas Lengauer
    In: Proceedings of the Fifteenth International Conference on Artificial Intelligence and Statistics (AISTATS 2012), La Palma, Canary Islands, Spain, 2012, 118-126
    
9. Predicting Response to Antiretroviral Treatment by Machine Learning: The EuResist Project
   Maurizio Zazzi, Francesca Incardona, Michal Rosen-Zvi, Mattia Prosperi, Thomas Lengauer, Andre Altmann, Anders Sonnerborg, Tamar Lavee, Eugen Schülter, and Rolf Kaiser
   Intervirology 55 (2): 123-127, 2012
   
8. Antiretroviral Therapy Optimisation without Genotype Resistance Testing: A Perspective on Treatment History Based Models
   Mattia C. F. Prosperi, Michal Rosen-Zvi, Andre Altmann, Maurizio Zazzi, Simona Di Giambenedetto, Rolf Kaiser, Eugen Schülter, Daniel Struck, Peter Sloot, David A. van de Vijver, Anne-Mieke Vandamme, and Anders Sönnerborg
   PLoS ONE 5 (10): e13753,1-e13753,8, 2010
   
7. Prediction of Response to Antiretroviral Therapy by Human Experts and by the EuResist Data-Driven Expert System (the EVE Study)
   Maurizio Zazzi, Rolf Kaiser, Anders Sönnerborg, Daniel Struck, Andre Altmann, Mattia C. F. Prosperi, Michal Rosen-Zvi, Andrea Petroczi, Yardena Peres, Eugen Schülter, Charles Boucher, Francoise Brun-Vezinet, Richard Harigan, Lynn Morris, Martin Obermeier, Federico Perno, Robert Shafer, Anne-Mieke Vandamme, Kristel van Laethem, Annemarie Wensing, Thomas Lengauer, and Francesca Incardona
   HIV Medicine Early View: 1-8, 2010
   
6. Investigation of expert rule bases, logistic regression, and non-linear machine learning techniques for predicting response to antiretroviral treatment
   Mattia C. F. Prosperi, André Altmann, Michal Rosen-Zvi, Ehud Aharoni, Borgulya Gabor, Bazso Fulop, Anders Sonnerborg, Eugen Schulter, Daniel Struck, Giovanni Ulivi, Anne-Mieke Vandamme, Jurgen Vercauteren, and Maurizio Zazzi
   Antiviral Therapy 14 (3): 433-442, 2009
   
5. EuResist: exploration of multiple modeling techniques for prediction of response to treatment
   Maurizio Zazzi, Ehud Aharoni, Andre Altmann, Fulop Baszó, Penny Bidgood, Gabór Borgulya, J Denholm-Prince, M Fielder, Rolf Kaiser, Carmel Kent, Thomas Lengauer, T Nepusz, Hanni Neuvirth, Yardena Peres, Andrea Petroczi, Mattia Prosperi, L Romano, Michal Rosen-Zvi, Eugen Schülter, Tobias Sing, Andras Sonnerborg, R Thompson, G Ulivi, L Zalány, and Francesca Incardona
   In: Proceedings of the 5th European HIV Drug Resistance Workshop, Cascais, Portugal, 2007
   
4. Comparison of Classifier Fusion Methods for Predicting Response to Anti HIV-1 Therapy
   Andre Altmann, Michal Rosen-Zvi, Mattia Prosperi, Ehud Aharoni, Hani Neuvirth, Anders Sönnerborg, Eugen Schülter, Joachim Büch, Daniel Struck, Yardena Peres, Francesca Incardona, Rolf Kaiser, Maurizio Zazzi, and Thomas Lengauer
   PLoS ONE 3 (10): e3470 p., 2008
   
3. Selecting anti-HIV therapies based on a variety of genomic and clinical factors
   Michal Rosen-Zvi, Andre Altmann, Mattia Prosperi, Ehud Aharoni, Hani Neuvirth, Anders Sönnerborg, Eugen Schülter, Daniel Struck, Yardena Peres, Francesca Incardona, Rolf Kaiser, Maurizio Zazzi, and Thomas Lengauer
   In: Proceedings of the 16th Annual International Conference on Intelligent Systems for Molecular Biology (ISMB 2008), Toronto, Canada, 2008, i399-406
   
2. Sustaining lamivudine/emtricitabine, abacavir, zidovudine or atazanavir from a previous treatment shows a clinical benefit
   Michal Rosen-Zvi, Eugen Schülter, Andre Altmann, Saleta Sierra-Aragon, Maurizio Zazzi, Anders Sönnerborg, Mark Oette, Thomas Lengauer, and Rolf Kaiser
   In: Antiviral Therapy, Sitges, Spain, 2008, A86 p.
   
1. The EuResist approach for predicting response to anti HIV-1 therapy
   Andre Altmann, Michal Rosen-Zvi, Mattia Prosperi, Ehud Aharoni, Hani Neuvirth, Eugen Schülter, Joachim Büch, Yardena Peres, Incardona Incardona, Anders Sönnerborg, Rolf Kaiser, Maurizio Zazzi, and Thomas Lengauer
   In: Reviews in Antiviral Therapy, Budapest, Hungary, 2008, 107 p.